Defined Culture Medium for Rapid iPS Cell Hepatoblast Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inducing differentiation of human induced pluripotent stem cells (iPS cells) into hepatocytes are inefficient, requiring several weeks and exposing cells to foreign proteins, with a risk of undifferentiated cells forming tumors upon transplantation.
Innovation Solution
A culture medium composition, including oncostatin M, hepatocyte functional proliferation inducer, M50054, non-essential amino acids, sodium pyruvate, and nicotinamide, is used to induce differentiation of iPS cells into hepatoblasts within 2 days, separating hepatoblasts from undifferentiated cells, thereby reducing tumor formation risk.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to induce differentiation of iPS cells into hepatocytes, then hepatocytes can be obtained, but the process requires several weeks and exposes cells to foreign proteins
Solution Approach 1:
The invention changes the chemical parameters of the culture medium by replacing conventional media containing foreign proteins with a defined medium containing specific small molecules (oncostatin M, hepatocyte functional proliferation inducer, M50054, non-essential amino acids, sodium pyruvate, and nicotinamide). This parameter change enables rapid differentiation within 2 days while eliminating foreign protein exposure, thus resolving the contradiction between safety and time.
2Reliability
If conventional differentiation methods are used, then hepatocytes can be produced, but undifferentiated cells remain and may form tumors upon transplantation
Solution Approach 1:
The invention extracts and removes undifferentiated iPS cells from the culture through selective elimination using the defined medium composition. The medium conditions cause undifferentiated cells to die while hepatoblasts survive and differentiate, effectively taking out the harmful undifferentiated cells that would form tumors, thereby improving reliability without reducing productivity.
Solution Approach 2:
The invention converts the harmful presence of undifferentiated cells into a benefit by using the defined medium to selectively eliminate them. The same medium conditions that promote hepatoblast differentiation also cause undifferentiated cells to die, thus converting the risk of tumor formation into a mechanism for purifying the cell product.
3Productivity
If growth factors and transcription factors are added to induce differentiation, then hepatocyte differentiation is promoted, but the process is complex and time-consuming
Solution Approach 1:
The invention replaces complex, expensive growth factors and transcription factors with a simpler combination of small molecules and defined medium components. This substitution uses shorter-acting, more stable compounds that achieve the same differentiation effect without the complexity and cost of protein-based factors, thus improving productivity while reducing medium complexity.
Solution Approach 2:
The invention changes the medium composition parameters from complex protein-based factors to a defined mixture of small molecules including oncostatin M, hepatocyte functional proliferation inducer, M50054, non-essential amino acids, sodium pyruvate, and nicotinamide. This parameter change simplifies the culture system while maintaining or enhancing differentiation speed.
Data Source
AI summary
Provided are a method of inducing differentiation of pluripotent stem cells, such as induced pluripotent stem cells (hereinafter abbreviated as iPS cells), to hepatocytes in a short period of time, and a substance to be used in the method. Specifically, provided are a method of producing a cell culture formed substantially of hepatoblasts, the method including culturing pluripotent stem cells, such as iPS cells, in a culture medium having a composition shown in Table 1 below, and a culture medium for inducing differentiation of pluripotent stem cells into hepatoblasts, which has a composition shown in Table 1 below.